JPMORGAN CHASE & CO - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,629
-99.9%
2,687,000
-31.6%
0.00%
-100.0%
Q3 2022$3,817,000
+44.2%
3,931,000
+44.4%
0.00%
Q2 2022$2,647,000
+906.5%
2,722,000
+915.7%
0.00%
Q1 2022$263,000
-93.4%
268,000
-93.6%
0.00%
-100.0%
Q4 2020$4,001,000
+1251.7%
4,208,000
+1194.8%
0.00%
Q3 2020$296,000
+9766.7%
325,000
+10733.3%
0.00%
Q2 2020$3,000
-99.8%
3,000
-99.8%
0.00%
Q1 2020$1,239,000
-57.7%
1,496,000
-55.8%
0.00%
-100.0%
Q4 2019$2,930,000
-2.9%
3,381,000
-3.3%
0.00%0.0%
Q2 2019$3,016,0003,496,0000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders